jump to content jump to footer

Medical University of Innsbruck: Radiomic Assessment of Radiation-Induced Alterations of Skeletal Muscle Composition in Head and Neck Squamous Cell Carcinoma within the Currently Clinically Defined Optimal Time Window for Salvage Surgery

This study [1] aimed to examine tissue changes in patients with head and neck squamous cell carcinoma (HNSCC) after primary radiochemotherapy (RCT) using radiomic feature analysis. Patients with locally advanced HNSCC frequently require primary RCT. Despite intensity modulation, the desired radiation-induced effects observed in HNSCC may also be observed as side effects in healthy tissue, e.g., the sternocleidomastoid muscle (SCM). The optimal time window for salvage surgery, a treatment often considered after primary RCT, is generally believed to be between 6 to 12 weeks post-RCT. This timeframe is largely determined by clinical studies focusing on surgical complications, rather than directly exploring radiation's impact on the SCM.

This study is the first to explore short-term RCT-induced skeletal muscle alterations after RCT in HNSCC patients applying radiomics, a data-driven approach aiming at extracting and processing quantitative data to analyze image-based information

Using the mint Lesion™ Radiomics module, researchers analyzed the CT scans of 98 HNSCC patients, focusing on three key radiomic parameters:  volume, mean positivity of pixels (MPP), and uniformity.

The study revealed a significant reduction in volume after primary RCT. Specifically, the SCM volume decreased from 9.0 to 8.4 mL, and the paravertebral musculature (PVM) volume dropped from 96.5 to 91.9 mL. This observed decrease was unexpected, as an increase was anticipated due to inflammation and edema in the SCM directly affected by irradiation. Moreover, a significant drop in PVM volumes was noted, which was primarily influenced by chemotherapy and not irradiation.

It was determined that these volume changes were unlikely to be caused solely by irradiation, chemotherapy, or their combination. In the course of the study, significant reductions were observed in both BMI (from 23.9 to 21.0 kg/m²) and serum protein levels (from 7.4 to 6.6 mg/%). These observed reductions were found to be closely correlated with the changes in volume. Once the results were adjusted for the variations in BMI, the volume changes for SCM and PVM post-treatment were rendered insignificant.

The findings of this study underscore the paramount importance of closely monitoring and optimizing patients' nutrition before, during, and after undergoing primary RCT. Previous studies have linked lower serum protein levels and BMI to increased complication rates in patients who later undergo salvage surgery. When accounting for changes in BMI, no significant alterations in muscle volume or other radiomic features indicative of tissue fibrosis were found. Thus, this study supports the existing clinical consensus that the best period for salvage surgery following RCT lies between 6 to 12 weeks.

Read the original publication here.

[1] Santer, M.; Riechelmann, H.; Hofauer, B.; Schmutzhard, J.; Freysinger, W.; Runge, A.; Gottfried, T.M.; Zelger, P.; Widmann, G.; Kranebitter, H.; et al. Radiomic Assessment of Radiation-Induced Alterations of Skeletal Muscle Composition in Head and Neck Squamous Cell Carcinoma within the Currently Clinically Defined Optimal Time Window for Salvage Surgery—A Pilot Study. Cancers 2023

Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?

Read more
Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion

Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…

Read more
Image of a patient getting an MRI scan, signifying how RACOON projects in Germany show how imaging, structured reporting, and AI jointly advance clinical research.
Overview of major RACOON projects in radiology and clinical research.
RACOON – Imaging, Data & Collaboration for Better Decisions

Modern radiology faces a central question: how can imaging and clinical data be combined in a way that leads to more precise diagnoses,…

Read more
scroll-top